The vast majority of estrogen-dependent breast cancers do not grow or metastasize in conventional PDX host strains (12, 13), with the largest study reporting a 2.5% engraftment rate of therapy-naïve luminal ER+ breast tumor xenografts (13). The gene discussed is ESR1; the disease is breast neoplasm.